DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

Similar documents
What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Antithrombotic therapy in CAD patients with concomitant NAFV: why and for whom?

Cardiac Arrhythmias in Acute Coronary Syndrome. Roj Rojjarekampai, MD Thammasart Hospital 26/5/59

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

Alex versus Xience Registry Preliminary report

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Approach to Multi Vessel disease with STEMI

Coronary Artery Disease: Revascularization (Teacher s Guide)

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

FastTest. You ve read the book now test yourself

Acute Coronary Syndrome. Sonny Achtchi, DO

STEMI AND MULTIVESSEL CORONARY DISEASE

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Belinda Green, Cardiologist, SDHB, 2016

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Patient characteristics Intervention Comparison Length of followup

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?

Common Codes for ICD-10

Polypharmacy - arrhythmic risks in patients with heart failure

Management of new-onset AF: Initial rate control treatment

Acute Coronary syndrome

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY

APPENDIX F: CASE REPORT FORM

The MAIN-COMPARE Study

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Stable Angina: Indication for revascularization and best medical therapy

When Should I Order a Stress Test or an Echocardiogram

Rate and Rhythm Control of Atrial Fibrillation

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

Rate Control versus Rhythm Control in NSTEMI

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

GRAND ROUNDS - DILEMMAS IN ANTICOAGULATION AND ANTIPLATELET THERAPY. Nick Collins February 2017

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Controversies in Cardiac Pharmacology

Samer Nasr, M.D. Mount Lebanon Hospital.

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

My Patient Needs a Stress Test

What do the guidelines say?

Atrial fibrillation (AF) is a disorder seen

Treatment strategy decision tree

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Electrocardiography. Hilal Al Saffar College of Medicine,Baghdad University

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Non ST Elevation-ACS. Michael W. Cammarata, MD

The ESC Registry on Chronic Ischemic Coronary Disease

National Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation

» A new drug s trial

Pre Hospital and Initial Management of Acute Coronary Syndrome

Dual Antiplatelet Therapy Made Practical

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

NSTE ACS. Timing of intervention

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Emergency surgery in acute coronary syndrome

NEWS ON ISCHEMIC HEART DISEASE AT THE ESC 2018 CONGRESS MARIO MARZILLI, MD, PhD

AF#in#pa(ents#with#CAD# Is#dronedarone#a#good#choice?!

Manuel Castella MD PhD Hospital Clínic, University of

Sheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017)

An update on the management of UA / NSTEMI. Michael H. Crawford, MD

Atrial fibrillation and mortality: where is the missing link? Isabelle C Van Gelder University Medical Center Groningen

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Rebuttal. Jerónimo Farré MD 2010

Cindy L. Grines MD FACC FSCAI

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Downloaded from:

Diagnostic, Technical and Medical

SUPPLEMENTARY INFORMATION

Acute Myocardial Infarction

Possible clinical and hemodynamic predictors of atrial fibrillation recurrence after catheter ablation

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

Chronic Total Occlusion: A case for coronary artery bypass grafting

Acute Coronary Syndrome

North Wales Cardiac Network Guidelines on oral antiplatelet therapy in cardiovascular disease

Chapter 4: Cardiovascular Disease in Patients With CKD

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

AF Ablation in Patients with Heart Failure

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Acute Coronary Syndromes

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Treatment of Atrial Fibrillation in Heart Failure

Transcription:

The Impact of AF on Natural History of CAD DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

CAD MOST COMMON CARDIOVASCULAR DISEASE MOST COMMON CAUSE OF DEATH (16,8%, 2013 VS 12% 1990) Lancet (2015) 9963, 117-71

CAD STEMI NSTE-ACS STABLE CAD ANGINA CABG PCI

MOST COMMON ARRHYTHMIA ATRIAL FIBRILLATION ONE IN FOUR MIDDLE-AGED ADULTS IN EUROPE AND THE US WILL DEVELOP AF AF PREVALENCE OF APPROXIMATELY 3% IN ADULTS AGED 20 YEARS OR OLDER, WITH GREATER PREVALENCE IN OLDER PERSONS (14% >80Y) European Heart Journal (2016) 37, 2893 2962

AF - PATTERNS PAROXYSMAL AF PERSISTENT AF LONG-STANDING PERSISTENT PERMANENT

AF AND CAD

AF AND CAD The prevalence of CAD in patients with AF ranges from 17% to 46,5% ROCKET-AF, RELY: CAD was present in 17% of the AF patients Kralev et al.(2011): 261 consecutive AF patients undergoing coronary angiography (without previously diagnosed or excluded CAD) showed that stable CAD was diagnosed in 13% of AF pts and in 21% of the pts PCI or CABG was performed, overall incidence of CAD was 34%. In older patients (>70y) the incidence of CAD was 41%.

AF AND CAD Lip et al.(1995): 46% των ασθενών με AF είχαν CAD Van Gelder et al. (2010) : σε 614 ασθενείς με μόνιμη AF το 18% είχαν CAD AFFIRM (2002): 38% ATHENA (2009): 30% 0,2-5% των ασθενών με CAD έχουν AF

AF AND CAD Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease Benjamin A. Steinberg et al, Europace, 2014 Apr AAD therapy and outcomes in 1738 older patients (age 65) with AF and CAD Concomitant atrial fibrillation (AF) and coronary artery disease (CAD) portend a poor prognosis yielding significant morbidity and mortality in older patients. At 5 years, rehospitalization exceeded 75% and mortality exceeded 33% Nearly one-third of patients with AF and CAD are treated with an antiarrhythmic drug (AAD), most commonly amiodarone.

AF AND STEMI

AF AND STEMI AF is the most frequent supraventricular arrhythmia AF, with up to 21% of STEMI patients affected Pre-existing, first-time detected, or of new onset AF

AF AND STEMI STEMI patients with documented AF have worse short- and long-term prognoses when compared with patients in sinus rhythm Presence of AF is associated with a higher reinfarction rate, higher stroke rate, higher risk for heart failure, and higher risk for sudden cardiac death Also transient, self-terminating AF during STEMI relates to a significantly higher stroke rate during long-term follow-up

Long term prognosis of atrial fibrillation in STelevation myocardial infarction patients undergoing percutaneous coronary intervention 1657 consecutive STEMI patients hospitalized in the cardiac intensive care unit during 2008-2014 NOAF was defined as AF occurring within 30days of the STEMI episode Patients were followed for a mean period of 3.4±2.1years 77 (4.6%) patients had paf and 47 (2.8%) had NOAF CONCLUSIONS: Prior AF and not new-onset AF is an independent predictor of both short and long term mortality in patients treated with PCI. Τopaz G et al, Int J Cardiol. 2017 Aug 1;240:228-233

Significance of Atrial Fibrillation Complicating ST- Segment Elevation Myocardial Infarction 4,363 consecutive STEMI patients treated invasively Finally, 4,099 subjects were included into further analysis, as 264 patients were excluded because of previous AF history New-onset AF was the independent predictor of death only in patients with anterior MI(hazard ratio 2.16) and this effect was stronger for late-onset AF (after 24H)(hazard ratio 2.86) In conclusion: The predictive value of new-onset AF was strongly related with STEMI location and timing of arrhythmia Podolecki T et al, Am J Cardiol. 2017 Aug 15;120(4):517-521

AF AND NSTE- ACS

AF AND NSTE-ACS Atrial fibrillation in its permanent or paroxysmal form is frequent in NSTE-ACS patients. The development of this arrhythmia occurs in 2 21% of patients with NSTE-ACS. Atrial fibrillation increases the risk of worsening ischemia, of developing heart failure and of thromboembolic complications. Atrial fibrillation complicating ACS is associated with increased in-hospital and long-term mortality. European Heart Journal doi:10.1093/eurheartj/ehv320

AF AND NSTE-ACS Thromboembolic MI in patients with AF Type 2 ΕΜ (NSTEMI)

AF AND NSTE - ACS GRACE (Global Registry of Acute Coronary Events): 21,785 patients with ACS, 1,700 (7.9%) had previous AF and 1,221 (6.2%) had new-onset AF Compared with patients with ACS without any AF, previous and new-onset AF are associated with increased hospital morbidity and mortality. Am J Cardiol. 2003 Nov 1;92(9):1031-6.

AF AND NSTE - ACS Increases in-hospital and long-term mortality irrespective of the time of occurrence. Relative mortality risk for patients with AF post MI is around 2.5 times that for patients without AF.

AF AND NSTE - ACS Depending on the duration of atrial fibrillation, heart rate, haemodynamics and functional status of the patient, different therapeutic actions are required, ranging from rate control to urgent electrical cardioversion

AF AND NSTE - ACS IC CAST N En J Med 1989 CAST Investigators

Recommendations for the management of patients with atrial fibrillation in the setting of non-stelevation acute coronary syndrome

Recommendations for the management of patients with atrial fibrillation in the setting of non-stelevation acute coronary syndrome

AF AND NSTE - ACS A particular diagnostic challenge results from the fact that patients with atrial fibrillation with rapid ventricular response may present with increased troponin levels as well as chest discomfort. In a large-scale atrial fibrillation trial, 9.2% of patients had elevated highsensitivity troponin I levels, and this proportion may be higher in the setting of acute-onset atrial fibrillation. Cardiac troponin dynamics in patients with atrial fibrillation and rapid ventricular rate may mimic type 1 MI. While in the presence of very high levels of troponin the likelihood of type 1 MI is high and coronary angiography is justified, in the majority of cases of atrial fibrillation and troponin elevation, ischemia detection should be considered first.

Recommendations for the management of patients with atrial fibrillation in the setting of non-stelevation acute coronary syndrome

Diagnostic accuracy of electrocardiographic STsegment depression in patients with rapid atrial fibrillation for the prediction of coronary artery disease 115 hemodynamically stable patients with AF, and a heart rate > 80% of their maximum predicted according to their age Group A included patients without any ST-segment abnormalities and group B patients with downward or horizontal ST-segment depression 1 mm in 2 or more contiguous leads. Prevalence of significant CAD among studied patients was 21.7%, 3/71 (4.2%) and 22/44 (50.0%) in group A and B, respectively In consecutive patients with rapid AF, the absence of ST-segment depression might indicate absence of CAD Tsigkas G et al, Can J Cardiol. 2014 Aug

AF AND STABLE CAD

Effect of atrial fibrillation on outcome in patients with known or suspected coronary artery disease referred for exercise stress testing 17,100 patients aged > or = 50 years with known or suspected CAD who underwent exercise electrocardiography (n = 11,911) or exercise echocardiography (n = 5,189) were evaluated. During a mean follow-up period of 6.5 + or - 3.9 years, 2,364 patients died, 1,311 had nonfatal myocardial infarctions, 1,615 underwent percutaneous coronary intervention, and 922 underwent coronary artery bypass surgery The 10-year mortality rate was 43% in patients with AF compared to 19% in those without AF (p <0.001). In multivariate analysis, AF remained an independent predictor of all-cause mortality (adjusted hazard ratio 1.45, 95% confidence interval 1.20 to 1.76, p <0.001), but not of nonfatal myocardial infarction or coronary revascularization. In conclusion AF was an independent predictor of all-cause mortality in patients with known or suspected CAD referred for exercise stress testing. Bouzas-Mosquera A et al, AM J Cardiol.2010 May 1;105(9):1207-11

Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease: a population-based study A total of 1947 AF patients were analyzed, of whom 40.5% had stable CAD Stable CAD was independently associated with increased risk of 1- year all-cause mortality. One-year outcomes in patients with and without stable CAD Ying Bai et al, J Geriatr Cardiol.2016 Aug; 13(8): 665 671

AF AND CABG

AF AND CABG Νew-onset post-operative AF may occur in one-third of patients undergoing isolated CABG During 2nd-4th days after CABG The presence of post-operative AF after CABG is independently associated with increased cardiac morbidity and mortality, prolonged hospitalization, increased healthcare expenditure, and poor long-term prognosis European Heart Journal (2014) 35, 2541 2619

Bedside Tool for Predicting the Risk of Postoperative Atrial Fibrillation After Cardiac Surgery: The POAF Score Μariscalco G et al, JAHA 2014

AF AND CABG Β-Blockers - 33 studies - 4700 patients 16.3% vs 31.7% Arsenault KA et al, The Cochrane Library 2013

AF AND CABG Carvedilol vs Placebo

AF AND CABG Carvedilol vs Metoprolol Wang HS et al, PLOS One 2015

AF AND CABG AMIODARONE 5402 patients 19.4% vs 33% Arsenault KA et al, The Cochrane Library 2013

AF AND CABG COLCHICINE ν=1412 maybe useful for prevention of AF Lennertz C et al, Int J Cardiol 2017

AF AND PCI

AF AND PCI New-onset AF : change from sinus rhythm at admission to AF during/after PCI 2 6% of procedures and increases with age, pre-existing heart failure, acute myocardial infarction and arterial hypertension During the first 4 days after acute myocardial infarction Impaired prognosis, more than doubling the risk of death, congestive heart failure and stroke European Heart Journal (2014) 35, 2541 2619

AF AND PCI Oral anticoagulation in addition to antiplatelet therapy appears to decrease the risk of stroke after PCI European Heart Journal (2014) 35, 2541 2619

AF AND PCI 2,096 patients undergoing ppci. New-onset AF occurred in 6.2% of patients. New-onset AF after ppci is associated with adverse 30- day outcomes Mrdovic I et al, Coron Artery Dis 2012;23(1):1 8 3,307 consecutive patients with and without AF (sinus rhythm) undergoing PCI from January 2007 through December 2008 enrolled in a multicenter Australian registry. Periprocedural AF was present in 4.9%. Patients with periprocedural AF represent a very high-risk group with increased morbidity and mortality Chan W et al, Am J Cardiol 2012;109(4):471 477 6,308 consecutive patients undergoing PCI with DES between 2002 and 2009. AF was present in 5.3%. AF confers an increased risk of all-cause mortality, ischaemic stroke, and intracranial bleeding (4y ). Pilgrim Tet al, Euro Intervention 2013;8(9):1061 1071

ΣΤΕΦΑΝΙΟΓΡΑΦΙΚΑ ΕΥΡΗΜΑΤΑ ΣΕ AF

ΣΤΕΦΑΝΙΟΓΡΑΦΙΚΑ ΕΥΡΗΜΑΤΑ ΣΕ AFχεία AF It is often speculated that atrial ischemia plays an important pathophysiological role in the genesis of AF. Hence significant stenosis in the proximal RCA and the Cx prior to the take-off of the atrial branches should increase the likelihood of AF in these patients Retrospective analysis of 3220 patients: only 43% of patients with CAD and AF showed a diseased right artery and/or circumflex branch of the left coronary artery. Further, in only 65% of these patients was coronary stenosis localized before the take-off of atrial branches Lokshyn S et al. Atrial fibrillation in coronary artery disease. Int J Cardiol. 2000;72(2):133 6

ΣΤΕΦΑΝΙΟΓΡΑΦΙΚΑ ΕΥΡΗΜΑΤΑ ΣΕ AF 261 consecutive patients admitted to hospital with paroxysmal, persistent or permanent AF in this prospective study In patients with stable CAD no significant difference in the location of coronary artery stenosis among LAD, LCX and RCA was found. Srefan Kralev et al, PloS one 2011; 6(9): e24964

AF AND CAD Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm Lukas J.et al, Hellenic Society of Cardiology (2017)

AF AND CAD In patients with stable CAD or MI undergoing coronary angiography, AF is not associated with the localization of coronary artery stenoses

CONCLUSIONS STEMI patients with documented AF have worse short- and long-term prognoses when compared with patients in sinus rhythm. Presence of AF is associated with a higher reinfarction rate, higher stroke rate, higher risk for heart failure, and higher risk for sudden cardiac death Also transient, self-terminating AF during STEMI relates to a significantly higher stroke rate during long-term follow-up Atrial fibrillation complicating ACS increases the risk of worsening ischemia, of developing heart failure and of thromboembolic complications and is associated with increased in-hospital and long-term mortality.

CONCLUSIONS The presence of post-operative AF after CABG is independently associated with increased cardiac morbidity and mortality, prolonged hospitalization, increased healthcare expenditure, and poor long-term prognosis Pre-operative anti-arrhythmic drug treatment may be initiated but will have to be weighed against side-effects. Beta-blockers significantly decrease the risk of AF after CABG. In patients with PCI AF confers an increased risk of all-cause mortality, ischemic stroke, intracranial bleeding and congestive heart failure.

The Impact of AF on Natural History of CAD DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI